Skip to content
Open access

Dynamics of the gut microbiome and metabolome in children during and after an infectious diarrheal episode

Aug 2026 · Frontiers in Cellular and Infection Microbiology · Vol 16 · 0 citations · 28 references
Medicine

TL;DR

It is suggested that recovery of the gut microbiota to a healthy condition may take longer and does not necessarily coincide with clinical recovery from diarrhea, and that butyrate levels decreased following clinical recovery, reaching values comparable to those found in the healthy samples.

Abstract

Introduction Acute diarrhea is associated with significant alterations in the gut microbiota and metabolome. Despite several studies documenting increased levels of histamine and short-chain fatty acids (SCFAs) during diarrheal episodes, the dynamics of these metabolites and microbiota following clinical recovery remain poorly understood, especially in children. Methods We evaluated the composition of the intestinal microbiota and the levels of histamine and SCFAs in stool samples from children under five years old with acute diarrhea and after clinical recovery. Additionally, a comparison with a sample of healthy children was included. Results Our results revealed significant differences in the community structure of the intestinal microbiota among the three conditions. The recovery samples exhibited a greater abundance of genera associated with diarrhea, such as Escherichia-Shigella, Streptococcus, Veillonella, and Akkermansia, as well as genera associated with healthy microbiota, such as Bifidobacterium. Regarding metabolites, butyrate levels decreased following clinical recovery, reaching values comparable to those found in the healthy samples, whereas histamine levels did not differ significantly among the conditions. Discussion Our findings suggest that, after clinical resolution of diarrhea, the gut microbiota and its metabolites remain significantly different from those observed in healthy children, possibly representing an intermediate stage between diarrhea and a healthy condition. These findings suggest that recovery of the gut microbiota to a healthy condition may take longer and does not necessarily coincide with clinical recovery from diarrhea.

Read PDF

Similar papers

Open access Sep 2026

Metagenomic and Metabolomic Signatures of Gut Microbiota After Helicobacter pylori Eradication Therapy Supplemented with Butyric Acid and Inulin: Observational Study

The long-term impact of eradication therapy for Helicobacter pylori on the gut microbiota is a subject of significant interest. To evaluate the influence of the bismuth-based quadruple H. pylori eradication therapy supplemented with butyrate and inulin on functional alterations within the gut microbial community, metag...

S. Abdulkhakov, D. D. Safina, Maria I. Markelova et al. · 0 citations
Open access Oct 2026

Characterization of Fecal Microbiota Alterations in Toddlers and Children with Acute Diarrhea Using 16S rRNA Gene Amplicon Sequencing

Acute diarrhea is associated with alterations in the gut microbiota, yet data from Indonesian pediatric populations remain limited. This study characterized the fecal microbiota of children and toddlers with acute diarrhea using 16S rRNA gene amplicon sequencing. A cross-sectional study was conducted on 24 pediatric pa...

R. I. Paramita, Fadilah Fadilah, Rahmat Apipi et al. · 0 citations
Open access Aug 2026

Characterization of gut microbiota in Vietnamese children under 5 years of age with acute and persistent diarrhea

Gut microbiota alterations have been increasingly associated with diarrheal diseases, a leading cause of morbidity and mortality in children under 5 years of age. However, explorations examining microbiota profiles across different diarrhea durations remain limited. Our study investigated microbiota alterations in Viet...

Nghia Chung, Tuan-Anh Nguyen, V. H. Pham et al. · 0 citations
Review Open access Oct 2026

Natural products regulate gut microbiota and SCFA metabolism in IBD: mechanisms and therapeutic potential

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic relapsing inflammatory condition of the gastrointestinal tract. Over the past few decades, the global incidence of this disease has continued to rise, imposing a heavy socioeconomic burden. IBD is typically char...

Bei-Hui He, Yu-Qian Xu, Yu-Jin Wang et al. · 0 citations
Open access Sep 2026

Comparative gut microbiome in diarrheal and non-diarrheal children: an individually matched case-control study

ABSTRACT Diarrhea, a leading cause of under-five mortality in developing countries, drives therapeutic challenges amid global antibiotic resistance. This study aimed to compare gut microbiota, antibiotic resistance genes (ARGs), mobile genetic elements (MGEs), and virulence factors (VFs) in diarrheal and non-diarrheal...

Jia-Liang Xu, Yu-Feng Fan, Ge-Ruo Qu et al. · 0 citations
Open access Aug 2026

THE ROLE OF THE GUT MICROBIOME IN THE DEVELOPMENT AND PROGRESSION OF GASTROINTESTINAL DISEASES: CURRENT EVIDENCE AND FUTURE PERSPECTIVES

The gut microbiome is a complex ecosystem consisting of bacteria, archaea, fungi, viruses, and other microorganisms that interact continuously with the intestinal epithelium, immune system, and metabolic pathways of the host. Increasing evidence demonstrates that alterations in the composition and function of the gut m...

Ulykbek Daurenov, Dana Suyunbay, Alua Toqseiıt et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.